Renal risk and response in amyloidosis
- PMID: 25301329
- DOI: 10.1182/blood-2014-08-596338
Renal risk and response in amyloidosis
Abstract
In this issue of Blood, Palladini and colleagues address incidence of and risk factors for end-stage renal disease (ESRD) and proffer a new renal response system for patients with amyloid light-chain (AL) amyloidosis using a test set of 461 patients from Pavia, Italy, and a validation set of 271 patients from Heidelberg, Germany. Validation of organ response criteria has trailed behind the progress made in the field of AL amyloidosis in diagnosis, prognosis, and hematologic response, but Palladini and colleagues' study helps breach this gap.
Comment on
-
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis.Blood. 2014 Oct 9;124(15):2325-32. doi: 10.1182/blood-2014-04-570010. Epub 2014 Aug 12. Blood. 2014. PMID: 25115890
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous

